These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34145657)
21. Should evolutionary geneticists worry about higher-order epistasis? Weinreich DM; Lan Y; Wylie CS; Heckendorn RB Curr Opin Genet Dev; 2013 Dec; 23(6):700-7. PubMed ID: 24290990 [TBL] [Abstract][Full Text] [Related]
22. Unraveling the causes of adaptive benefits of synonymous mutations in TEM-1 β-lactamase. Zwart MP; Schenk MF; Hwang S; Koopmanschap B; de Lange N; van de Pol L; Nga TTT; Szendro IG; Krug J; de Visser JAGM Heredity (Edinb); 2018 Nov; 121(5):406-421. PubMed ID: 29967397 [TBL] [Abstract][Full Text] [Related]
24. Epistatic interactions determine the mutational pathways and coexistence of lineages in clonal Escherichia coli populations. Maharjan RP; Ferenci T Evolution; 2013 Sep; 67(9):2762-8. PubMed ID: 24033182 [TBL] [Abstract][Full Text] [Related]
25. Genomic evolution of antibiotic resistance is contingent on genetic background following a long-term experiment with Card KJ; Thomas MD; Graves JL; Barrick JE; Lenski RE Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33441451 [TBL] [Abstract][Full Text] [Related]
26. On the deformability of an empirical fitness landscape by microbial evolution. Bajić D; Vila JCC; Blount ZD; Sánchez A Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11286-11291. PubMed ID: 30322921 [TBL] [Abstract][Full Text] [Related]
27. Adaptation Through Lifestyle Switching Sculpts the Fitness Landscape of Evolving Populations: Implications for the Selection of Drug-Resistant Bacteria at Low Drug Pressures. Matange N; Hegde S; Bodkhe S Genetics; 2019 Mar; 211(3):1029-1044. PubMed ID: 30670539 [TBL] [Abstract][Full Text] [Related]
28. Quantifying the adaptive potential of an antibiotic resistance enzyme. Schenk MF; Szendro IG; Krug J; de Visser JA PLoS Genet; 2012 Jun; 8(6):e1002783. PubMed ID: 22761587 [TBL] [Abstract][Full Text] [Related]
29. Pervasive Pairwise Intragenic Epistasis among Sequential Mutations in TEM-1 β-Lactamase. Gonzalez CE; Ostermeier M J Mol Biol; 2019 May; 431(10):1981-1992. PubMed ID: 30922874 [TBL] [Abstract][Full Text] [Related]
30. Evolution of Robustness to Protein Mistranslation by Accelerated Protein Turnover. Kalapis D; Bezerra AR; Farkas Z; Horvath P; Bódi Z; Daraba A; Szamecz B; Gut I; Bayes M; Santos MA; Pál C PLoS Biol; 2015; 13(11):e1002291. PubMed ID: 26544557 [TBL] [Abstract][Full Text] [Related]
31. Adaptive benefits from small mutation supplies in an antibiotic resistance enzyme. Salverda MLM; Koomen J; Koopmanschap B; Zwart MP; de Visser JAGM Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12773-12778. PubMed ID: 29133391 [TBL] [Abstract][Full Text] [Related]
32. Negative Epistasis and Evolvability in TEM-1 β-Lactamase--The Thin Line between an Enzyme's Conformational Freedom and Disorder. Dellus-Gur E; Elias M; Caselli E; Prati F; Salverda ML; de Visser JA; Fraser JS; Tawfik DS J Mol Biol; 2015 Jul; 427(14):2396-409. PubMed ID: 26004540 [TBL] [Abstract][Full Text] [Related]
33. Mutational events in cefotaximase extended-spectrum beta-lactamases of the CTX-M-1 cluster involved in ceftazidime resistance. Novais A; Cantón R; Coque TM; Moya A; Baquero F; Galán JC Antimicrob Agents Chemother; 2008 Jul; 52(7):2377-82. PubMed ID: 18443114 [TBL] [Abstract][Full Text] [Related]
35. Perspective: Sign epistasis and genetic constraint on evolutionary trajectories. Weinreich DM; Watson RA; Chao L Evolution; 2005 Jun; 59(6):1165-74. PubMed ID: 16050094 [TBL] [Abstract][Full Text] [Related]
36. Negative epistasis between beneficial mutations in an evolving bacterial population. Khan AI; Dinh DM; Schneider D; Lenski RE; Cooper TF Science; 2011 Jun; 332(6034):1193-6. PubMed ID: 21636772 [TBL] [Abstract][Full Text] [Related]
37. Predictable Phenotypes of Antibiotic Resistance Mutations. Knopp M; Andersson DI mBio; 2018 May; 9(3):. PubMed ID: 29764951 [TBL] [Abstract][Full Text] [Related]
38. Evolvability as a function of purifying selection in TEM-1 β-lactamase. Stiffler MA; Hekstra DR; Ranganathan R Cell; 2015 Feb; 160(5):882-892. PubMed ID: 25723163 [TBL] [Abstract][Full Text] [Related]
39. Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance. Chevereau G; Dravecká M; Batur T; Guvenek A; Ayhan DH; Toprak E; Bollenbach T PLoS Biol; 2015; 13(11):e1002299. PubMed ID: 26581035 [TBL] [Abstract][Full Text] [Related]
40. Probing evolutionary repeatability: neutral and double changes and the predictability of evolutionary adaptation. Roy SW PLoS One; 2009; 4(2):e4500. PubMed ID: 19234610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]